Shojania K: Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis

Wong IT, Shojania K, Dutz J, Tsao NW. Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis. Expert Rev Pharmacoecon Outcomes Res. Epub ahead of print 2015 Dec 17. PMID: 26681527.